IDYA: IDEAYA Biosciences, Inc. Stock

by  •  • Comments Off on IDYA: IDEAYA Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,965.46
Enterprise Value ($M) 1,565.18
Book Value ($M) 1,180.42
Book Value / Share 13.66
Price / Book 1.67
NCAV ($M) 872.76
NCAV / Share 10.10
Price / NCAV 2.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 22.93
Current Ratio 22.93

Balance Sheet (mrq) ($M)
Current Assets 932.21
Assets 1,239.87
Liabilities 59.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Janus Henderson Group Plc 6.10 45.34
11-14 13G/A Price T Rowe Associates Inc /md/ 4.80 12.51
11-14 13G/A Biotechnology Value Fund L P 1.70 -59.47
11-12 13G/A Fmr Llc 14.96 54.84
02-14 13G/A Avidity Partners Management LP 2.40 -60.26
02-13 13G/A Logos Global Management LP 2.80 -53.85
02-13 13G Vanguard Group Inc 5.39
02-07 13G/A Adage Capital Partners Gp, L.l.c. 4.54 12.44
02-01 13G/A Canaan X L.p. 2.40 -40.96
01-25 13G/A BlackRock, Inc. 8.40 53.72
01-18 13G/A Federated Hermes, Inc. 6.03 35.58

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q/A Amendment No. 1 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 102,814 417,196 24.64
2025-01-14 257,590 983,070 26.20
2025-01-13 134,311 552,884 24.29
2025-01-10 120,775 505,273 23.90

(click for more detail)

Similar Companies
HUMA – Humacyte, Inc. IBRX – ImmunityBio, Inc.
IDXX – IDEXX Laboratories, Inc. IFRX – InflaRx N.V.
IGMS – IGM Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io